Kytogenics Pharmaceuticals, Inc.
Home | Contact Us | Site Map.
Kytogenics Pharmaceuticals, Inc.


510K Products

Kytogenics represents an attractive, late stage investment opportunity in its wound care line.

NOCC™ Hydrophilic Wound Dressing

Kytogenics' received its first 510K FDA clearance for its NOCC™ Hydrophilic Wound Dressing on March 14, 2008. The Company has expertise in the preparation of sterile solutions and gels of NOCC from its experience in developing products for the surgical adhesion prevention markets, which can be used as hydrophilic solutions for wound fillers. The advantage of this product over most other wound fillers is that it is bioresorbable and does not have to be irrigated out of the wound.  Kytogenics considers its NOCC Technology as the building block for the future expansion of wound care products which the Company also plans to out-license.